Jefferson Transplant Institute Liver, Kidney Transplant Programs Earn Recognition from SRTR
June 02, 2017
PHILADELPHIA — Jefferson Health’s Transplant Institute earned a laudable four star score from the Scientific Register of Transplant Recipients (SRTR). The SRTR evaluates the patient survival and organ functionality one year after their transplantation, and then assigns a score of one (the worst) to five (the best).
The Jefferson Transplant Institute was the only program in Philadelphia to earn four stars, and it is only one of two in Pennsylvania.
“Our ranking in the SRTR report is a tribute to our team’s ongoing commitment to outstanding care for our patients,” said Cataldo Doria, MD, PhD, MBA, Director of the Jefferson Transplant Institute and the Nicoletti Family Professor of Transplant Surgery at the Sidney Kimmel Medical College at Thomas Jefferson University. “This dedication to care makes it possible for the Jefferson Transplant Institute to grow in recognition and stature—and in its ability to continue to give the gift of life.”
The Jefferson Transplant Institute performs approximately 70 liver and 95 kidney transplants per year, each with a one-year survival rate over 90 percent.
Jefferson performed the first liver transplant in the Delaware Valley in 1984 and has completed more than 1,000 liver transplants since—boasting one of the shortest times for liver transplantation of any medical center in the Delaware Valley. By creating seven-day, expedited evaluation program, Jefferson can rapidly screen patients for transplant in five days and place them on the liver transplant waitlist in one week. The Jefferson Transplant Institute is also among the highest volume programs in the U.S. for paired kidney exchanges and desensitization for patients with immunologic sensitivities.
Among its key functions, the SRTR provides statistical and other analytic support to the Organ Procurement and Transplantation Network (OPTN) for purposes including the formulation and evaluation of organ allocation in the United States. Its findings on national transplant data, and the research it conducts on solid-organ transplantation in the U.S. is shared publically—from transplant candidates and recipients, to living donors and donor families, to organ procurement organizations and transplant programs— with the goal of improving patient outcomes.